DD231355A5 - Verfahren zur herstellung von neuen 2-phenyl-unidazolen - Google Patents
Verfahren zur herstellung von neuen 2-phenyl-unidazolen Download PDFInfo
- Publication number
- DD231355A5 DD231355A5 DD84271864A DD27186484A DD231355A5 DD 231355 A5 DD231355 A5 DD 231355A5 DD 84271864 A DD84271864 A DD 84271864A DD 27186484 A DD27186484 A DD 27186484A DD 231355 A5 DD231355 A5 DD 231355A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- group
- methoxy
- general formula
- radicals
- atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833347290 DE3347290A1 (de) | 1983-12-28 | 1983-12-28 | Neue 2-phenyl-imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD231355A5 true DD231355A5 (de) | 1985-12-24 |
Family
ID=6218292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD84271864A DD231355A5 (de) | 1983-12-28 | 1984-12-27 | Verfahren zur herstellung von neuen 2-phenyl-unidazolen |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4722929A (fi) |
| EP (1) | EP0149200A1 (fi) |
| JP (1) | JPS60172980A (fi) |
| KR (1) | KR850004476A (fi) |
| AU (1) | AU3721184A (fi) |
| DD (1) | DD231355A5 (fi) |
| DE (1) | DE3347290A1 (fi) |
| DK (1) | DK610284A (fi) |
| ES (6) | ES537992A0 (fi) |
| FI (1) | FI845117L (fi) |
| GR (1) | GR82597B (fi) |
| HU (1) | HUT37618A (fi) |
| IL (1) | IL73951A0 (fi) |
| NO (1) | NO845252L (fi) |
| PT (1) | PT79755B (fi) |
| ZA (1) | ZA8410057B (fi) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3217583A1 (de) * | 1982-05-11 | 1983-11-17 | Merck Patent Gmbh, 6100 Darmstadt | 2-aryl-tetraazaindene |
| DE3346640A1 (de) * | 1983-12-23 | 1985-07-04 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue imidazolderivate, deren herstellung und diese verbindungen enthaltende arzneimittel |
| DE3446812A1 (de) * | 1984-12-21 | 1986-06-26 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue imidazoderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel |
| US4783530A (en) * | 1986-11-13 | 1988-11-08 | Marion Laboratories, Inc. | 8-arylxanthines |
| IL94390A (en) * | 1989-05-30 | 1996-03-31 | Merck & Co Inc | The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them |
| US5332744A (en) * | 1989-05-30 | 1994-07-26 | Merck & Co., Inc. | Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists |
| US5223499A (en) * | 1989-05-30 | 1993-06-29 | Merck & Co., Inc. | 6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists |
| US5064825A (en) * | 1989-06-01 | 1991-11-12 | Merck & Co., Inc. | Angiotensin ii antagonists |
| JPH06107661A (ja) * | 1991-10-24 | 1994-04-19 | Upjohn Co:The | イミダゾール誘導体およびこれを有効成分とする医薬組成物 |
| US5442062A (en) * | 1991-10-24 | 1995-08-15 | The Upjohn Company | Imidazole derivatives and pharmaceutical compositions containing the same |
| CA2156918A1 (en) * | 1993-02-26 | 1994-09-01 | Deen Tulshian | 2-benzyl-polycyclic guanine derivatives and process for preparing them |
| US5646156A (en) * | 1994-04-25 | 1997-07-08 | Merck & Co., Inc. | Inhibition of eosinophil activation through A3 adenosine receptor antagonism |
| WO1999062905A1 (en) * | 1998-06-03 | 1999-12-09 | Almirall Prodesfarma, S.A. | 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors |
| GB9914825D0 (en) * | 1999-06-24 | 1999-08-25 | Smithkline Beecham Spa | Novel compounds |
| ES2166270B1 (es) * | 1999-07-27 | 2003-04-01 | Almirall Prodesfarma Sa | Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona. |
| US6887690B2 (en) * | 2001-06-22 | 2005-05-03 | Pe Corporation | Dye-labeled ribonucleotide triphosphates |
| US7101883B2 (en) * | 2002-03-18 | 2006-09-05 | Bristol-Myers Squibb Company | Uracil derivatives as inhibitors of TNF-α converting enzyme (TACE) and matrix metalloproteinases |
| SE0301446D0 (sv) | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | New Compounds |
| JP4127204B2 (ja) * | 2003-12-17 | 2008-07-30 | セイコーエプソン株式会社 | 液晶表示装置の製造方法 |
| TW200736227A (en) | 2005-12-23 | 2007-10-01 | Astrazeneca Ab | New compounds III |
| TWI433839B (zh) * | 2006-08-11 | 2014-04-11 | Neomed Inst | 新穎的苯并咪唑衍生物290 |
| EP2246335A1 (de) * | 2009-02-17 | 2010-11-03 | Bayer CropScience AG | Aminopyrimidinamide als Schädlingsbekämpfungsmittel |
| CN115124534B (zh) * | 2021-11-23 | 2023-09-15 | 中山大学 | 非核苷酸类prmt5小分子抑制剂、制备方法及用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1186504A (en) * | 1966-10-15 | 1970-04-02 | Fisons Pest Control Ltd | Substituted Heterocyclic Compounds |
| US3985891A (en) * | 1973-02-03 | 1976-10-12 | Boehringer Ingelheim Gmbh | 2-Phenyl-imidazo (4,5-b)pyridines and salts thereof |
| DE2305339C3 (de) * | 1973-02-03 | 1980-05-08 | Dr. Karl Thomae Gmbh, 7950 Biberach | Imidazo [4,5-b] pyridine, ihre Herstellung und ihre Verwendung als Cardiötonica |
| DE2927987A1 (de) * | 1979-07-11 | 1981-02-05 | Thomae Gmbh Dr K | Neue 2-alkoxyphenyl-imidazo eckige klammer auf 4,5-b eckige klammer zu pyridine, deren herstellung und deren verwendung als arzneimittel |
| DE3037464A1 (de) * | 1980-10-03 | 1982-05-19 | Dr. Karl Thomae Gmbh, 7950 Biberach | 6-hydroxy-2-phenyl-imidazo 4,5-b zu pyridine, ihre herstellung und diese sie enthaltende arzneimittel |
| DE3108027A1 (de) * | 1981-03-03 | 1982-09-16 | Dr. Karl Thomae Gmbh, 7950 Biberach | Mittel zur behandlung von koronaren herzerkrankungen |
| ES8401486A1 (es) * | 1981-11-10 | 1983-12-01 | Wellcome Found | Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina. |
| US4452788A (en) * | 1982-04-21 | 1984-06-05 | Warner-Lambert Company | Substituted 8-phenylxanthines |
| RO86850B (ro) * | 1982-05-03 | 1985-05-31 | Eli Lilly And Company | Procedeu pentru prepararea unor 2-fenilimidazo [4,5 c] piridine |
| DE3217583A1 (de) * | 1982-05-11 | 1983-11-17 | Merck Patent Gmbh, 6100 Darmstadt | 2-aryl-tetraazaindene |
| DE3346602A1 (de) * | 1983-12-23 | 1985-07-11 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue imidazo(4,5-c)pyridin-one, deren herstellung und diese verbindungen enthaltende arzneimittel |
-
1983
- 1983-12-28 DE DE19833347290 patent/DE3347290A1/de not_active Withdrawn
-
1984
- 1984-11-27 ES ES537992A patent/ES537992A0/es active Granted
- 1984-12-19 DK DK610284A patent/DK610284A/da unknown
- 1984-12-20 US US06/684,052 patent/US4722929A/en not_active Expired - Fee Related
- 1984-12-20 EP EP84116009A patent/EP0149200A1/de not_active Withdrawn
- 1984-12-25 JP JP59281991A patent/JPS60172980A/ja active Pending
- 1984-12-27 IL IL73951A patent/IL73951A0/xx unknown
- 1984-12-27 NO NO845252A patent/NO845252L/no unknown
- 1984-12-27 FI FI845117A patent/FI845117L/fi not_active Application Discontinuation
- 1984-12-27 GR GR82597A patent/GR82597B/el unknown
- 1984-12-27 ZA ZA8410057A patent/ZA8410057B/xx unknown
- 1984-12-27 DD DD84271864A patent/DD231355A5/de unknown
- 1984-12-27 KR KR1019840008436A patent/KR850004476A/ko not_active Application Discontinuation
- 1984-12-27 PT PT79755A patent/PT79755B/pt unknown
- 1984-12-27 HU HU844843A patent/HUT37618A/hu unknown
- 1984-12-28 AU AU37211/84A patent/AU3721184A/en not_active Abandoned
-
1985
- 1985-05-13 ES ES543082A patent/ES543082A0/es active Granted
- 1985-05-13 ES ES543084A patent/ES8603883A1/es not_active Expired
- 1985-05-13 ES ES543083A patent/ES543083A0/es active Granted
- 1985-05-13 ES ES543085A patent/ES8603884A1/es not_active Expired
- 1985-05-13 ES ES543086A patent/ES8603885A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NO845252L (no) | 1985-07-01 |
| HUT37618A (en) | 1986-01-23 |
| ES543084A0 (es) | 1986-01-01 |
| ES8603882A1 (es) | 1986-01-01 |
| DE3347290A1 (de) | 1985-07-11 |
| ES543085A0 (es) | 1986-01-01 |
| ES8603883A1 (es) | 1986-01-01 |
| ES543086A0 (es) | 1986-01-01 |
| PT79755A (de) | 1985-01-01 |
| DK610284A (da) | 1985-06-29 |
| FI845117A0 (fi) | 1984-12-27 |
| ES8603884A1 (es) | 1986-01-01 |
| IL73951A0 (en) | 1985-03-31 |
| ES8603881A1 (es) | 1986-01-01 |
| AU3721184A (en) | 1985-07-04 |
| ES8601992A1 (es) | 1985-11-01 |
| ES537992A0 (es) | 1985-11-01 |
| PT79755B (de) | 1986-12-10 |
| JPS60172980A (ja) | 1985-09-06 |
| US4722929A (en) | 1988-02-02 |
| FI845117L (fi) | 1985-06-29 |
| ES8603885A1 (es) | 1986-01-01 |
| GR82597B (en) | 1985-04-29 |
| DK610284D0 (da) | 1984-12-19 |
| ZA8410057B (en) | 1986-09-24 |
| ES543083A0 (es) | 1986-01-01 |
| EP0149200A1 (de) | 1985-07-24 |
| ES543082A0 (es) | 1986-01-01 |
| KR850004476A (ko) | 1985-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD231355A5 (de) | Verfahren zur herstellung von neuen 2-phenyl-unidazolen | |
| EP0098448A2 (de) | Neue Imidazolderivate, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE69636671T2 (de) | Pyrido[2,3-]-pyrimidine und deren Verwendung beim Inhibieren von Zellproliferation und Protein-Tyrosin-Kinase-Enzymaktivität | |
| EP0299470B1 (de) | Imidazo[1,2-a]pyridine | |
| DE60016566T2 (de) | Triazolopyridazinderivate als liganden für gaba-rezeptoren | |
| DE2614406A1 (de) | Tetracyclische verbindungen, verfahren zu deren herstellung und arzneimittel, enthaltend diese verbindungen | |
| EP0209707A2 (de) | Neue 2-Arylimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| EP0502314A1 (de) | Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| DE2818676A1 (de) | Substituierte 5,6-dimethylpyrrolo 2,3-d pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| EP0130461A2 (de) | Neue Imidazole, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DD242407A5 (de) | Verfahren zur herstellung von imidazoderivaten | |
| DE3701277A1 (de) | Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel | |
| EP0185346A2 (de) | Neue Imidazoderivate, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE60115466T2 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
| DE2720085C2 (fi) | ||
| EP0611660A2 (de) | Kondensierte 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE4212748A1 (de) | Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| EP0556789A2 (de) | Substituierte Biphenylylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| DE3346575A1 (de) | Neue benzimidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel | |
| EP0184738A2 (de) | Neue Imidazoderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| DE3146599A1 (de) | Neue triazolochinazoline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| EP0148438A2 (de) | Neue Imidazolderivate, deren Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| EP0331093A1 (de) | Neue Benzimidazo[1,2-c] chinazoline, ihre Herstellung und Verwendung | |
| EP0047412B1 (de) | Neue Pyrazine, deren Herstellung und diese enthaltende Arzneimittel | |
| DD215545A5 (de) | Verfahren zur herstellung eines (1,2,4)triazolo (4,3-a)chin-oxalin-4-amin-derivats |